DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Vaillant A, Bazinet M, Pantea V. et al.
FRI-343 – Updated follow-up analysis in the REP 401 protocol: Treatment HBeAg negative chronic hepatitis B infection with REP 2139 or REP 2165, tenofovir disoproxil fumarate and pegylated interferon alfa-2a.
Journal Of Hepatology 2018;
68: S517
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.